Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution. (Q43411833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bastiaan Tops

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Sandra H E Boots-Sprenger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Angelique Sijben

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jos Rijntjes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Albert J Idema

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Andreana L Rivera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Fonnet E Bleeker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Anja M Gijtenbeek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kristin Diefes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Lindsey Heathcock

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kenneth D Aldape

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Judith W M Jeuken

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

1 reference

22 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

922-929

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Diffuse glioma growth: a guerilla war

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Risk of false positive results in comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Genetic profile of astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

The Nature and Timing of Specific Copy Number Changes in the Course of Molecular Progression in Diffuse Gliomas: Further Elucidation of Their Genetic “Life Story”

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Impact of genotype and morphology on the prognosis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Molecular diagnostics of gliomas: the clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Age-dependent prognostic effects of genetic alterations in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Molecular diagnostics of gliomas: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Two types of chromosome 1p losses with opposite significance in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Molecular classification of low-grade diffuse gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Molecular markers in low-grade gliomas: predictive or prognostic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

Molecular genetic alterations in glioblastomas with oligodendroglial component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

inferred from DOI database lookup

7 January 2021

based on heuristic

Multiplex ligation-dependent probe amplification for the detection of 1p and 19q chromosomal loss in oligodendroglial tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

inferred from DOI database lookup

7 January 2021

based on heuristic

Re: multiplex ligation dependent probe amplification for the detection of 1p and 19q loss in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.166

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2012.166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

24 February 2020

1009261408

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429602%20AND%20SRC:MED&resulttype=core&format=json